2024-03-19 16:36:02 ET
More on Moleculin Biotech
Read the full article on Seeking Alpha
For further details see:
Moleculin Biotech to implement a 1-for-15 reverse stock split2024-03-19 16:36:02 ET
Read the full article on Seeking Alpha
For further details see:
Moleculin Biotech to implement a 1-for-15 reverse stock splitMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress PR Newswire HOUSTON , May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage ...
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06) PR Newswire – Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin ...
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire – Recently announced interim data from ongoing MB-106 study demonstrating Annamycin in combination with Cytarabine (AnnAraC) achieves CRc rate of 62% (54% CR) in 1 st an...